NTNX vs. RXST

Last updated Apr 2, 2026

Compare and contrast key facts about Nutanix, Inc. (NTNX) and RxSight, Inc. (RXST).

Performance

NTNX vs. RXST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nutanix, Inc. (NTNX) and RxSight, Inc. (RXST). The values are adjusted to include any dividend payments, if applicable.

NTNX vs. RXST - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
NTNX Nutanix, Inc.	-26.41%	-15.51%	28.29%	83.07%	-18.24%	-11.55%
RXST RxSight, Inc.	-39.16%	-69.69%	-14.73%	218.23%	12.62%	-29.69%

Fundamentals

Market Cap NTNX : $11.19B RXST : $261.05M
EPS NTNX : $0.90 RXST : -$0.95
PS Ratio NTNX : 4.20 RXST : 1.93
Total Revenue (TTM) NTNX : $2.69B RXST : $134.48M
Gross Profit (TTM) NTNX : $2.34B RXST : $103.01M
EBITDA (TTM) NTNX : $300.04M RXST : -$38.63M

Returns By Period

In the year-to-date period, NTNX achieves a -26.41% return, which is significantly higher than RXST's -39.16% return.

NTNX

• 1D: 0.08%
• 1M: -5.58%
• YTD: -26.41%
• 6M: -49.64%
• 1Y: -45.50%
• 3Y*: 13.54%
• 5Y*: 6.92%
• 10Y*: —

RXST

• 1D: 2.92%
• 1M: -16.69%
• YTD: -39.16%
• 6M: -29.63%
• 1Y: -74.86%
• 3Y*: -27.56%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

NTNX vs. RXST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NTNX

NTNX Risk / Return Rank: 7
NTNX Sharpe Ratio Rank: 4
NTNX Sortino Ratio Rank: 6
NTNX Omega Ratio Rank: 6
NTNX Calmar Ratio Rank: 11
NTNX Martin Ratio Rank: 8

RXST

RXST Risk / Return Rank: 7
RXST Sharpe Ratio Rank: 6
RXST Sortino Ratio Rank: 6
RXST Omega Ratio Rank: 5
RXST Calmar Ratio Rank: 3
RXST Martin Ratio Rank: 16

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NTNX vs. RXST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nutanix, Inc. (NTNX) and RxSight, Inc. (RXST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NTNX	RXST	Difference
Sharpe ratio Return per unit of total volatility	-1.00	-0.90	-0.10
Sortino ratio Return per unit of downside risk	-1.39	-1.42	+0.03
Omega ratio Gain probability vs. loss probability	0.82	0.79	+0.03
Calmar ratio Return relative to maximum drawdown	-0.82	-0.98	+0.16
Martin ratio Return relative to average drawdown	-1.53	-1.23	-0.30
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NTNX vs. RXST - Sharpe Ratio Comparison

The current NTNX Sharpe Ratio is -1.00, which is comparable to the RXST Sharpe Ratio of -0.90. The chart below compares the historical Sharpe Ratios of NTNX and RXST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	NTNX	RXST	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-1.00	-0.90	-0.10
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.14	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.01	-0.26	+0.27

Correlation

The correlation between NTNX and RXST is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

NTNX vs. RXST - Dividend Comparison

Neither NTNX nor RXST has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

NTNX vs. RXST - Drawdown Comparison

The maximum NTNX drawdown since its inception was -80.40%, smaller than the maximum RXST drawdown of -90.53%. Use the drawdown chart below to compare losses from any high point for NTNX and RXST.

Drawdown Indicators

	NTNX	RXST	Difference
Max Drawdown Largest peak-to-trough decline	-80.40%	-90.53%	+10.13%
Max Drawdown (1Y) Largest decline over 1 year	-55.63%	-76.68%	+21.05%
Max Drawdown (5Y) Largest decline over 5 years	-68.71%	—	—
Current Drawdown Current decline from peak	-54.21%	-90.14%	+35.93%
Average Drawdown Average peak-to-trough decline	-40.46%	-34.66%	-5.80%
Ulcer Index Depth and duration of drawdowns from previous peaks	29.68%	60.95%	-31.27%

Volatility

NTNX vs. RXST - Volatility Comparison

The current volatility for Nutanix, Inc. (NTNX) is 9.58%, while RxSight, Inc. (RXST) has a volatility of 14.89%. This indicates that NTNX experiences smaller price fluctuations and is considered to be less risky than RXST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NTNX	RXST	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.58%	14.89%	-5.31%
Volatility (6M) Calculated over the trailing 6-month period	34.40%	43.99%	-9.59%
Volatility (1Y) Calculated over the trailing 1-year period	45.69%	83.69%	-38.00%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	48.92%	69.16%	-20.24%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	57.11%	69.16%	-12.05%

Financials

NTNX vs. RXST - Profitability Comparison

The chart below illustrates the profitability comparison between Nutanix, Inc. and RxSight, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

NTNX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Nutanix, Inc. reported a gross profit of 631.55M and revenue of 722.83M. Therefore, the gross margin over that period was 87.4%.

RXST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, RxSight, Inc. reported a gross profit of 25.26M and revenue of 32.61M. Therefore, the gross margin over that period was 77.5%.

NTNX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Nutanix, Inc. reported an operating income of 84.33M and revenue of 722.83M, resulting in an operating margin of 11.7%.

RXST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, RxSight, Inc. reported an operating income of -11.34M and revenue of 32.61M, resulting in an operating margin of -34.8%.

NTNX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Nutanix, Inc. reported a net income of 103.02M and revenue of 722.83M, resulting in a net margin of 14.3%.

RXST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, RxSight, Inc. reported a net income of -9.15M and revenue of 32.61M, resulting in a net margin of -28.1%.